India Launches Global Study on Ayurveda TB Integration

  • 26 Mar 2026

On 24th March 2026, marking World Tuberculosis Day, India launched a first-of-its-kind global clinical study to evaluate the integration of Ayurveda with standard tuberculosis treatment.

Key Points

  • bjective: To assess Ayurveda as an adjunct to standard Anti-Tuberculosis Treatment (ATT) for improved recovery and patient outcomes.
  • Scale of Study:
  • Over 1,200 patients involved.
  • Will be conducted across leading institutions in India.
  • Focus Areas:
  • Nutritional recovery and weight gain
  • Disease progression
  • Quality of life
  • Safety and treatment tolerability
  • Holistic Approach: Combines modern biotechnology with traditional knowledge to provide patient-centric, comprehensive care.
  • India’s Progress in TB Control:
  • 21% decline in TB incidence since 2015.
  • Cases reduced to ~187 per 100,000 population (2024).
  • Driven by the National TB Elimination Programme.
  • Key Challenges Addressed:
  • Drug resistance
  • Treatment toxicity
  • Undernutrition
  • Linkages with diseases like diabetes